Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.88
+0.54 (8.52%)
At close: Dec 20, 2024, 4:00 PM
6.54
-0.34 (-4.94%)
After-hours: Dec 20, 2024, 5:54 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 109 employees as of December 31, 2023. The number of employees decreased by 13 or -10.66% compared to the previous year.
Employees
109
Change (1Y)
-13
Growth (1Y)
-10.66%
Revenue / Employee
$199,754
Profits / Employee
-$723,788
Market Cap
324.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Canopy Growth | 1,029 |
Cerus | 637 |
Sage Therapeutics | 487 |
AVITA Medical | 207 |
Rigel Pharmaceuticals | 147 |
Nyxoah | 147 |
Aclaris Therapeutics | 91 |
enGene Holdings | 33 |
SLN News
- 3 days ago - Top 3 Health Care Stocks That May Explode In Q4 - Benzinga
- 12 days ago - Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting - Business Wire
- 25 days ago - Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 4 weeks ago - Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst - Benzinga
- 4 weeks ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 4 weeks ago - Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting - Business Wire
- 5 weeks ago - Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 5 weeks ago - Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference - Business Wire